Author

Monty B. Mazer

Case Western Reserve UniversityORCID 0000-0002-4159-8585Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew H. WaltoniD· 1 shared Anne M. DrewryiD· 1 shared Charles C. CaldwelliD· 1 shared Dale F. Osborne· 1 shared Ethan Davitt· 1 shared Ivanna L. Rocha· 1 shared Kenneth E. RemyiD· 1 shared Lyle L. MoldaweriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andrew H. WaltonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Determining potential immunomodulatory drug efficacy in sepsis using ELISpot

Andrew H. Walton, Monty B. Mazer, Kenneth E. Remy, Dale F. Osborne, Ethan Davitt, Thomas S. Griffith, Robert W. Gould, Vladimir P. Badovinac, Scott C. Brakenridge, Anne M. Drewry, Ricardo F. Ungaro, Ivanna L. Rocha, Tyler John Loftus, Philip Alexander Efron, Lyle L. Moldawer, , Richard S. Hotchkiss

This study uses ELISpot to assess immunomodulatory drug effects on cytokine production in sepsis patients and healthy controls.

Scientific Reports · Apr 18, 2025Peer-reviewedImmunology